In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co has
increased its holding of B shares in Novozymes to 5.10%, previously reported at
4.999% in company announcement no. 36, July 2016.
Baillie Gifford & Co now holds B shares in Novozymes A/S to a total of
15,798,286 shares of a nominal value of DKK 31,596,572, equivalent to 5.10% of
Novozymes A/S’ share capital and 1.99% of the voting rights.